ThursdayJun 01, 2017 8:43 am

ABcann Medicinals (TSXV: ABCN) Eyes Growing Role on Canadian Marijuana Market, Extends Agreement with MMJ Pioneer

One of the most dominant and experienced growers of quality medical marijuana on the Canadian market, ABcann Medicinals (TSXV: ABCN), has entered a stage of aggressive growth after launching its first initial public offering (IPO) on the TSX Venture Exchange earlier this month. Recently acquired by ABcann Global Corporation, an acquisition that came with a $26.8 million capital raise to help expand production, the company is already licensed to sell to the entire Canadian market and plans to significantly expand production to reach this goal. In addition, ABcann also plans to sign partnerships to sell to the U.S. market, as…

Continue Reading

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

Continue Reading

WednesdayMay 03, 2017 1:04 pm

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market. With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is…

Continue Reading

TuesdayMay 02, 2017 2:20 pm

ABcann Medicinals Set to Launch IPO This Week on TSXV

According to efficient markets theory, the chances of finding hundred-dollar bills lying on the ground are slim, at best. When one is dropped, some well-informed investor is quick to pick it up. However, with Abcann Medicinals set to launch its initial public offering (IPO) on the TSX Venture Exchange on May 4, the chances of finding those elusive hundreds have increased significantly. Investors will have an opportunity to take up shares in one of Canada’s major legal cannabis producers. With the marijuana recreational market in Canada set for legalization, the Abcann Medicinals IPO will level the playing field and offer…

Continue Reading

WednesdaySep 28, 2016 10:01 am

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Teams with Leading Marketing Firms to Build Brand Awareness

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) took a significant step toward expanding market awareness of its hemp-based functional beverage products when it announced a new partnership with digital marketing experts ArDoMi Media Group and C&I Studios. The two firms are expected to collaborate on the creation of a marketing campaign highlighting both Caffe, Laguna’s instant hot coffee beverage, and Pro369, the company’s water soluble hemp protein product. Through this campaign, Laguna Blends will look to amplify its brand visibility in target areas while simultaneously expanding the reach of its affiliate network into unexplored…

Continue Reading

FridaySep 23, 2016 10:57 am

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Included in the Canadian Securities Exchange Composite Index

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) announced its inclusion on the Canadian Securities Exchange (CSE) Composite index. Criteria for inclusion on the CSE Composite index include active listing on the CSE, a market capitalization of at least $5 million and a seasoning requirement. At each quarterly rebalance, companies included in the index are assessed to ensure a minimum market capitalization of at least $4 million, with companies that fail to meet this criteria being subject to index deletion. The market cap of Laguna Blends was listed at $6.34 million as of September 19,…

Continue Reading

TuesdaySep 20, 2016 9:08 am

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Receives Second Report from Fundamental Research Corp.

Fundamental Research Corp. (FRC), a company in the business of providing quality equity research coverage since 2003, recently released its second report on Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F), a rapidly growing multi-level marketing (MLM) company focused on the sale of functional, hemp-based beverages. FRC released its first report on May 5, 2016, giving Laguna a BUY rating and fair value estimate of $0.45 per share. According to the original report, the company’s shares were expected to range from $0.30 to $1.06, depending on the number of affiliates LAGBF generates by 2020. Since this initial coverage, Laguna’s share…

Continue Reading

MondaySep 19, 2016 9:14 am

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Game Changing Cannaceuticals Skin Care Product Line Launches via Affiliate Network

Described as a game-changing product line unlike any other available on the market, Laguna Blends, Inc.’s (CSE: LAG) (OTC: LAGBF) (LB6A.F) Cannaceuticals Skin Care Anti-Aging Collection finally launched on Thursday, September 15, being available only through the company’s affiliate network to existing members, as well as to any newcomers who want to join or simply resell these innovative products. It is the first skincare product line to use anti-aging cannabidiol (CBD). Consisting of seven main products, the CBD7 Complete Anti-Aging Collection offers next-generation skincare innovation for women and men alike, being superior to any other products on the market, according…

Continue Reading

WednesdaySep 14, 2016 9:12 am

Fundamental Research Reaffirms Buy Rating on Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F)

Analyst Siddharth Rajeev of Fundamental Research Corp. (“FRC”) recently reaffirmed the firm’s Buy rating on Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F), citing an increase in the company’s share price as well as improved revenue and its entrance into the lucrative skin care industry. Read the full report here http://nnw.fm/G8XvK Laguna Blends is a network marketing company focused on the generation of sales through a growing base of independent affiliates. In March of 2016, the company launched sales of its Caffe and Pro369 beverage products, marketing the products through a base of 135 affiliates in North America. As noted…

Continue Reading

WednesdayAug 31, 2016 4:26 pm

With Hemp-based Drinks, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) is Strongly Rooted in Functional Beverages Market

If you plan to visit Laguna Beach in Orange County, California, to attend the Food & Wine Pairing Dinner on September 1, 2016, you may not be aware that the area is associated with culinary delights other than vino. Located midway between Los Angeles and San Diego, and stretching for over seven miles, Laguna Beach has lent its name to Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F), a network marketing company with products based on the nutritional health benefits derived from hemp. Just like wine, the consumption of hemp beverages is still an avant-garde pursuit. Nevertheless, its management team…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000